The cellular and molecular basis of co-artemether (artemether-lumefantrine) action

The cellular and molecular basis of co-artemether (artemether-lumefantrine) action

Bibliographic Details
Main Author:	Makanga, Michael Musakiriza
Published:	University of Liverpool 2002
Subjects:	616 Antimalarial agents
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269599

Similar Items

Adverse reaction to Coartem (artemether/lumefantrine) resulting in oculogyric crisis
by: Emmanuel Kofi Amponsah, et al.
Published: (2021-05-01)

Does artemether–lumefantrine administration affect mosquito olfactory behaviour and fitness?
by: Jetske G. de Boer, et al.
Published: (2019-01-01)

Efficacy of artesunate–amodiaquine, dihydroartemisinin–piperaquine and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger
by: Francesco Grandesso, et al.
Published: (2018-01-01)

Artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers
by: Asinya, M., et al.
Published: (2022)

In vivo efficacy of artemether–lumefantrine against uncomplicated Plasmodium falciparum malaria in Dembia District, northwest Ethiopia
by: Deressa T, et al.
Published: (2017-02-01)

Therapeutic efficacy of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015–2016
by: Youssouf Diarra, et al.
Published: (2021-05-01)

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
by: Sileshi Belew, et al.
Published: (2020-04-01)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
by: Tarning Joel, et al.
Published: (2010-10-01)

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
by: Adama Gansané, et al.
Published: (2021-01-01)

Quality Assessment of Artemether-Lumefantrine Samples and Artemether Injections Sold in the Cape Coast Metropolis
by: James Prah, et al.
Published: (2016-01-01)

Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?
by: Gbadoé Adama, et al.
Published: (2010-01-01)

Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017
by: Elizabeth Davlantes, et al.
Published: (2018-04-01)

The impact of retail sector delivery of artemether-lumefantrine on effective malaria treatment of children under five in Kenya
by: Kangwana, Beth Bonareri Pamba
Published: (2011)

Use of artemether-lumefantrine in the treatment of asymptomatic-malaria infection in HIV-positive and HIV-negative Nigerian adults
by: Chijioke-Nwauche, I. N.
Published: (2014)

Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation
by: Shah SMH, et al.
Published: (2016-11-01)

The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.
by: Quique Bassat
Published: (2011-12-01)

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India
by: Dev Vas, et al.
Published: (2009-05-01)

Artemether/Lumefantrine for the Treatment of P. malariae in a Patient on Hemodialysis
by: Rita Patrocínio-Jesus, et al.
Published: (2019-01-01)

Studies on the molecular basis of chloroquine resistance in Plasmodium falciparum
by: Johnson, David James
Published: (2003)

The influence of host and parasite transporters on the pharmacodynamics of co-artemether
by: Ekuban, Frederick Ayensu
Published: (2006)

Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial
by: Krause Eike, et al.
Published: (2008-09-01)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
by: Snow Robert W, et al.
Published: (2008-01-01)

Quality of fixed dose artemether/lumefantrine products in Jimma Zone, Ethiopia
by: Sileshi Belew, et al.
Published: (2019-07-01)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
by: Prakash Ghimire, et al.
Published: (2018-08-01)

Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children
by: Sagara Issaka, et al.
Published: (2009-10-01)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
by: Ssekitooleko James, et al.
Published: (2008-09-01)

Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine
by: Gavin G. Rutledge, et al.
Published: (2017-08-01)

Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda
by: Rulisa Stephen, et al.
Published: (2012-07-01)

Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania
by: Mugoyela V, et al.
Published: (2011-09-01)

Formulation, process development and evaluation of artemether and lumefantrine soft gelatin capsule
by: A Patel, et al.
Published: (2012-01-01)

Artemether&ndash;lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
by: Stephan Ehrhardt, et al.
Published: (2009-10-01)

Green Analytical Methods of Antimalarial Artemether-Lumefantrine Analysis for Falsification Detection Using a Low-Cost Handled NIR Spectrometer with DD-SIMCA and Drug Quantification by HPLC
by: Moussa Yabré, et al.
Published: (2020-07-01)

A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated <it>Plasmodium falciparum </it>malaria in children in western Kenya
by: Akhwale Willis S, et al.
Published: (2008-12-01)

Quantitation of artemether in pharmaceutical raw material and injections by high performance liquid chromatography
by: Isabela da Costa César, et al.
Published: (2009-12-01)

In vitro effects of co-incubation of blood with artemether/lumefantrine & vitamin C on the viscosity & elasticity of blood
by: M G McKoy, et al.
Published: (2016-01-01)

Monitoring of the Sensitivity In Vivo of <i>Plasmodium falciparum</i> to Artemether-Lumefantrine in Mali
by: Modibo Diarra, et al.
Published: (2021-01-01)

Possible treatment failure of artemether-lumefantrine in an Italian traveler with uncomplicated falciparum malaria.
by: Claudio Giacomazzi, et al.
Published: (2011-01-01)

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya
by: Sudoi Raymond K, et al.
Published: (2012-02-01)

Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
by: Liusheng Huang, et al.
Published: (2017-01-01)

Plasmodium falciparum gametocyte dynamics after pyronaridine–artesunate or artemether–lumefantrine treatment
by: Johanna M. Roth, et al.
Published: (2018-06-01)